A new study analyzed how often people develop severe side effects after taking semaglutide — known by brand names Ozempic and ...

The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first ...

Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...

Researchers say semaglutide, the medication in Ozempic and Wegovy, may help reverse MASH, a progressive liver condition ...

The WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity ...

More than 2.5 billion adults worldwide are currently overweight or obese, according to estimates from the World Health ...

Semaglutide medications like Ozempic and Wegovy have exploded in popularity in recent years due to their effectiveness in diabetes control and weight ... loss in clinical trials of the drugs ...

Blue Cross Blue Shield of Massachusetts, the state's largest health insurer, recently announced that it will roll back ...

Mukhopadhyay took Mounjaro, an antidiabetic medication also used for weight loss, and saw dramatic results—losing 15 percent ...

“I’m actually ok with a little weight gain," the former Playboy star said Steve Kondiles/Bauer-Griffin/GC Images Kendra Wilkinson said she tried a weight-loss drug but stopped after one ...

“Real Housewives of New Jersey” star Jennifer Fessler learned that the hard way when she suffered a painful side effect from a GLP-1 weight loss drug after she “ignored” her doctor’s advice.

The Centers for Medicare & Medicaid Services on Friday rejected a Biden administration proposal to expand Medicare coverage of weight-loss drugs such as Eli Lilly's Zepbound and Novo Nordisk's ...